Investor Presentaiton
Select Key Financial Metrics
(in 000s) unless indicated
Q4-19
Q4-18
% CHANGE
FISCAL 2019
FISCAL 2018
% CHANGE
Gross revenue
Excise taxes
Net revenue
19,235
3,190
503%
97,547
12,429
685%
(2,945)
n/m
(17,134)
n/m
16,290
3,190
411%
80,413
12,429
547%
Cost of sales (incl. indirect production)
15,543
1,586
880%
42,521
6,814
524%
Gross margin (GM) before FV changes
747
1,604
(53)%
37,892
5,615
575%
FV changes to bio assets & inventories
Gross margin
(11,806)
30,846
n/m
10,577
46,018
(77)%
(11,059)
32,450
n/m
48,469
51,633
(6)%
SG&A¹
13,883
3,567
289%
33,218
10,989
202%
Net income (loss) from continuing ops
(22,456)
18,091
n/m
(9,504)
22, 124
n/m
Select Non-IFRS Metrics
GM before FV changes as % of net revenue
5%
50%
(46)%
47%
45%
2%
SG&A as a % of net revenue
85%
112%
(27)%
41%
88%
(47)%
Adjusted EBITDA²
(7,907)
292
n/m
19,900
(1,003)
n/m
Adjusted EBITDA as a % of net revenue²
n/m
9%
n/m
25%
n/m
n/m
1 Sales and marketing and general and administrative expenses (excludes noncash share based compensation and impairment loss)
Adjusted EBITDA is a nonIFRS measure -please see final slide.
19
2
ORGANIGRAMView entire presentation